Anne Li May 13th, 2017
Researchers have discovered epigenetic changes that contribute to one-fifth of cases of acute myeloid leukemia (AML), an aggressive cancer that arises out of the blood-forming cells in bone marrow. The mutations also play a role in a large majority of low-grade gliomas, which are among the most-treatable brain tumors.
See original article at: https://www.sciencedaily.com/releases/2017/05/170510140749.htm